… a meta-analysis to investigate the improvement in mortality or hospitalization rates and
adverse events among COVID-19 patients with three new oral antivirals (including molnupiravir, …

… meta-analysis is to evaluate the efficacy of molnupiravir among mild or moderate COVID-19
patients. This meta-analysis … Items for Systematic Reviews and Meta-Analyses. Two authors …

… Our analysis does not support routine use of molnupiravir for COVID-19 treatment in … We
found that early treatment with molnupiravir probably does not reduce the combined outcome ‘…

… Regarding the hospitalization rate, two studies reported the hospitalization rate in the
current meta-analysis and demonstrated that molnupiravir was associated with a similar …

… out meta-analyses on safety [18], and some studies only carried out meta-analyses on …
is to summarize and analyze the efficacy and safety of molnupiravir treatment for COVID-19 …

… efficacy and safety of molnupiravir need reassessment. Therefore, … molnupiravir for the
treatment of non-severe (mild or moderate) COVID-19, and conduct subgroup analyses and meta-…

… of molnupiravir in treating patients with mild to moderate COVID-19. Our findings reveal that
molnupiravir … and patients can consider molnupiravir as an option for the treatment of mild or …

… a meta-analysis on the AEs of various doses of molnupiravir versus placebo using
Comprehensive Meta-Analysis … analyses of safety outcome of molnupiravir for treatment of …

… mortality with molnupiravir treatment.We share your concerns about the efficacy of molnupiravir,
… In addition, there have been multiple studies showing that molnupiravir may cause new …

… This study is to evaluate benefit of adding Molnupiravir over standard treatments in mild
COVID-19 subjects. Cochrane Central Register of Controlled Trials: CTRI/2021/06/033938. …